Evidence map›Paper›PMID 31900153›Full record

ArticleJournal of biomedical science2020

Dopamine D

Pi-Kai Chang, Jung Chu, Ya-Ting Tsai, Yan-Heng Lai, Jin-Chung Chen

Open access · diamondAbstract read
In one paragraph

Article in Journal of biomedical science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Pi-Kai ChangDepartment of Physiology and Pharmacology, Graduate Institute of Biomedical Sciences, School of Medicine, Chang Gung University, Taoyuan, Taiwan.
Jung ChuDepartment of Biomedical Sciences, School of Medicine, Chang Gung University, Taoyuan, Taiwan.
Ya-Ting TsaiDepartment of Biomedical Sciences, School of Medicine, Chang Gung University, Taoyuan, Taiwan.
Yan-Heng LaiDepartment of Medical Imaging and Radiological Sciences, School of Medicine, Chang Gung University, Taoyuan, Taiwan.
Jin-Chung ChenDepartment of Physiology and Pharmacology, Graduate Institute of Biomedical Sciences, School of Medicine, Chang Gung University, Taoyuan, Taiwan. jinchen@mail.cgu.edu.tw.ORCID http://orcid.org/0000-0003-2996-5781
Chang Gung University · TWChang Gung University of Science and Technology · TW

Funding

Chang Gung Memorial Hospital, Linkou CMRPD1D0293Chang Gung Memorial Hospital, Linkou CMRPD1F0481Ministry of Education EMRPD1H0321Ministry of Education EMRPD1H551Ministry of Science and Technology, Taiwan 105-2320-B-182-012-MY2
6 · The paper itself

Abstract

backgroundOver-stimulation of dopamine signaling is thought to underlie the pathophysiology of a list of mental disorders, such as psychosis, mania and attention-deficit/hyperactivity disorder. These disorders are frequently associated with cognitive deficits in attention or learning and memory, suggesting that persistent activation of dopamine signaling may change neural plasticity to induce cognitive or emotional malfunction.

methodsDopamine transporter knockdown (DAT-KD) mice were used to mimic a hyper-dopamine state. Novel object recognition (NOR) task was performed to assess the recognition memory. To test the role of dopamine D

resultsWe confirmed our previous findings that DAT-KD mice displayed a deficit in NOR memory, which could be prevented by deletion of D

conclusionThese findings suggest that D

Indexed as

AnimalsBipolar DisorderCognitive DysfunctionDopamineDopamine Plasma Membrane Transport ProteinsGene Knockdown TechniquesGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaHumansMAP Kinase Signaling SystemMemory, EpisodicMicePrefrontal CortexReceptors, Dopamine D3DopamineDopamine Plasma Membrane Transport ProteinsGlycogen Synthase Kinase 3glycogen synthase kinase 3 alphaGlycogen Synthase Kinase 3 betaReceptors, Dopamine D3DopamineDopamine D3 receptorDopamine transporter knockdown (DAT-KD)Glycogen synthase kinase 3 (GSK3)Medial prefrontal cortex (mPFC)Novel object recognition (NOR)

Identifiers

PMID31900153
PMCPMC6942274
OpenAlexW3000368937

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.